Sensei Biotherapeutics Inc (SNSE)

Sensei Biotherapeutics Inc Azioni (SNSE) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	7.22% 8.73	8.142	7.737	10.18	11.01
Interest Income/Expense	9.68% 0.028	0.031	0.033	0.038	0.042
Operating Income/Loss	7.22% -8.73	-8.142	-7.737	-10.18	-11.01
Income/Loss From Continuing Operations Before Tax	53.81% -7.992	-17.30	-7.124	-9.386	-10.18
Income Tax Expense/Benefit	100.00% -	-9.89	-	-	-
Income/Loss From Continuing Operations After Tax	7.80% -7.992	-7.414	-7.124	-9.386	-10.18
Net Income/Loss	7.80% -7.992	-7.414	-7.124	-9.386	-10.18
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,630% 25.05	-0.9899	25.51	30.51	30.87
Diluted Average Shares	2,630% 25.05	-0.9899	25.51	30.51	30.87
Basic Earnings Per Share	6.67% -0.32	-0.30	-0.28	-0.31	-0.33
Diluted Earnings Per Share	6.67% -0.32	-0.30	-0.28	-0.31	-0.33
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-